491 related articles for article (PubMed ID: 11943824)
21. REST/NRSF-induced changes of ChAT protein expression in the neocortex and hippocampus of the 3xTg-AD mouse model for Alzheimer's disease.
Orta-Salazar E; Aguilar-Vázquez A; Martínez-Coria H; Luquín-De Anda S; Rivera-Cervantes M; Beas-Zarate C; Feria-Velasco A; Díaz-Cintra S
Life Sci; 2014 Oct; 116(2):83-9. PubMed ID: 25261598
[TBL] [Abstract][Full Text] [Related]
22. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.
Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E
Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468
[TBL] [Abstract][Full Text] [Related]
23. Cholinergic deafferentation of the rabbit cortex: a new animal model of Abeta deposition.
Beach TG; Potter PE; Kuo YM; Emmerling MR; Durham RA; Webster SD; Walker DG; Sue LI; Scott S; Layne KJ; Roher AE
Neurosci Lett; 2000 Mar; 283(1):9-12. PubMed ID: 10729621
[TBL] [Abstract][Full Text] [Related]
24. Selective vulnerability of different types of commissural neurons for amyloid beta-protein-induced neurodegeneration in APP23 mice correlates with dendritic tree morphology.
Capetillo-Zarate E; Staufenbiel M; Abramowski D; Haass C; Escher A; Stadelmann C; Yamaguchi H; Wiestler OD; Thal DR
Brain; 2006 Nov; 129(Pt 11):2992-3005. PubMed ID: 16844716
[TBL] [Abstract][Full Text] [Related]
25. The type of Aβ-related neuronal degeneration differs between amyloid precursor protein (APP23) and amyloid β-peptide (APP48) transgenic mice.
Rijal Upadhaya A; Scheibe F; Kosterin I; Abramowski D; Gerth J; Kumar S; Liebau S; Yamaguchi H; Walter J; Staufenbiel M; Thal DR
Acta Neuropathol Commun; 2013 Nov; 1(1):77. PubMed ID: 24252227
[TBL] [Abstract][Full Text] [Related]
26. Loss of cholinergic pathways in vascular dementia of the Binswanger type.
Tomimoto H; Ohtani R; Shibata M; Nakamura N; Ihara M
Dement Geriatr Cogn Disord; 2005; 19(5-6):282-8. PubMed ID: 15785029
[TBL] [Abstract][Full Text] [Related]
27. Neuropeptide alterations in the hippocampal formation and cortex of transgenic mice overexpressing beta-amyloid precursor protein (APP) with the Swedish double mutation (APP23).
Diez M; Danner S; Frey P; Sommer B; Staufenbiel M; Wiederhold KH; Hökfelt T
Neurobiol Dis; 2003 Dec; 14(3):579-94. PubMed ID: 14678773
[TBL] [Abstract][Full Text] [Related]
28. Intracellular Aß triggers neuron loss in the cholinergic system of the APP/PS1KI mouse model of Alzheimer's disease.
Christensen DZ; Bayer TA; Wirths O
Neurobiol Aging; 2010 Jul; 31(7):1153-63. PubMed ID: 18771817
[TBL] [Abstract][Full Text] [Related]
29. Distinct subsets of nucleus basalis neurons exhibit similar sensitivity to excitotoxicity.
Harkany T; Varga C; Grosche J; Mulder J; Luiten PG; Hortobágyi T; Penke B; Härtig W
Neuroreport; 2002 May; 13(6):767-72. PubMed ID: 11997684
[TBL] [Abstract][Full Text] [Related]
30. Stable beta-secretase activity and presynaptic cholinergic markers during progressive central nervous system amyloidogenesis in Tg2576 mice.
Gau JT; Steinhilb ML; Kao TC; D'Amato CJ; Gaut JR; Frey KA; Turner RS
Am J Pathol; 2002 Feb; 160(2):731-8. PubMed ID: 11839594
[TBL] [Abstract][Full Text] [Related]
31. 17beta-estradiol enhances cortical cholinergic innervation and preserves synaptic density following excitotoxic lesions to the rat nucleus basalis magnocellularis.
Horvath KM; Hårtig W; Van der Veen R; Keijser JN; Mulder J; Ziegert M; Van der Zee EA; Harkany T; Luiten PG
Neuroscience; 2002; 110(3):489-504. PubMed ID: 11906788
[TBL] [Abstract][Full Text] [Related]
32. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.
Buttini M; Yu GQ; Shockley K; Huang Y; Jones B; Masliah E; Mallory M; Yeo T; Longo FM; Mucke L
J Neurosci; 2002 Dec; 22(24):10539-48. PubMed ID: 12486146
[TBL] [Abstract][Full Text] [Related]
33. Tumor necrosis factor-alpha triggers cell death of sensitized potassium chloride-stimulated cholinergic neurons.
Zassler B; Weis C; Humpel C
Brain Res Mol Brain Res; 2003 May; 113(1-2):78-85. PubMed ID: 12750009
[TBL] [Abstract][Full Text] [Related]
34. Electrophysiological studies on the hippocampus and prefrontal cortex assessing the effects of amyloidosis in amyloid precursor protein 23 transgenic mice.
Roder S; Danober L; Pozza MF; Lingenhoehl K; Wiederhold KH; Olpe HR
Neuroscience; 2003; 120(3):705-20. PubMed ID: 12895511
[TBL] [Abstract][Full Text] [Related]
35. Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss.
Takeuchi A; Irizarry MC; Duff K; Saido TC; Hsiao Ashe K; Hasegawa M; Mann DM; Hyman BT; Iwatsubo T
Am J Pathol; 2000 Jul; 157(1):331-9. PubMed ID: 10880403
[TBL] [Abstract][Full Text] [Related]
36. Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease.
Lehéricy S; Hirsch EC; Cervera-Piérot P; Hersh LB; Bakchine S; Piette F; Duyckaerts C; Hauw JJ; Javoy-Agid F; Agid Y
J Comp Neurol; 1993 Apr; 330(1):15-31. PubMed ID: 8468401
[TBL] [Abstract][Full Text] [Related]
37. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration.
Salehi A; Delcroix JD; Belichenko PV; Zhan K; Wu C; Valletta JS; Takimoto-Kimura R; Kleschevnikov AM; Sambamurti K; Chung PP; Xia W; Villar A; Campbell WA; Kulnane LS; Nixon RA; Lamb BT; Epstein CJ; Stokin GB; Goldstein LS; Mobley WC
Neuron; 2006 Jul; 51(1):29-42. PubMed ID: 16815330
[TBL] [Abstract][Full Text] [Related]
38. Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease.
Baker-Nigh A; Vahedi S; Davis EG; Weintraub S; Bigio EH; Klein WL; Geula C
Brain; 2015 Jun; 138(Pt 6):1722-37. PubMed ID: 25732182
[TBL] [Abstract][Full Text] [Related]
39. Disease-related regressive alterations of forebrain cholinergic system in SOD1 mutant transgenic mice.
Crochemore C; Peña-Altamira E; Virgili M; Monti B; Contestabile A
Neurochem Int; 2005 Apr; 46(5):357-68. PubMed ID: 15737434
[TBL] [Abstract][Full Text] [Related]
40. Loss of Cholinergic and Monoaminergic Afferents in
Lee MK; Chen G
Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
